Ono Pharmaceutical to dispute suit filed by Nobel laureate

Ono Pharmaceutical to dispute suit filed by Nobel laureate

File photo taken June 5, 2020, shows the headquarters of Ono Pharmaceutical Co. in Osaka. The company said in a press release issued July 6 that it will "dispute and cope" with a lawsuit filed by Japanese Nobel laureate in medicine Tasuku Honjo the previous month over patent royalties for the cancer treatment drug Opdivo developed based on the discovery of his research team.

  • Product Code
  • ILEA000196244
  • Registered date
  • 2020/7/06 17:14:53
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2020 Kyodo News
  • Media size
  • 2645 × 3968 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 1.37(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Fast Retailing chief to donate 10 bil. yen to medical research

    Fast Retailing chief to donate 10 bil. yen to medical research

    Tadashi Yanai (C), chairman and CEO of Fast Retailing Co., the operator of casual wear chain Uniqlo, poses for a photo with two Nobel Prize winners -- Tasuku Honjo (L) and Shinya Yamanaka -- at a press conference in Kyoto on June 24, 2020, after announcing that he will donate a total of 10 billion yen ($93 million) to Kyoto University to support its medical research under the two scientists. (Kyodo) ==Kyodo
      U.S. court orders Takeda to pay $6 billion

      U.S. court orders Takeda to pay $6 billion

      TOKYO, Japan - File photo taken in October 2010 shows the Tokyo headquarters of Takeda Pharmaceutical Co. The company said Sept. 4, 2014, it has been ordered by a U.S. district court to pay $6 billion in punitive damages over a lawsuit filed by a man who claimed his bladder cancer was caused by Takeda's diabetes medicine Actos. Takeda plans to counter the move through legal means, including the option of appealing to a higher court, company officials said.